Labcorp Holdings Inc. (LH): Capital Expenditures
$434.50M
Year ended 2025-12-31
$483.20M
Trailing 12 months to 2026-06-30
+0.4%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $434.50M | -11.3% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $489.90M | +8.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $453.60M | +5.7% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $429.30M | +1.9% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $421.50M | n/c | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $381.70M | -4.6% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $400.20M | +5.4% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $379.80M | +21.4% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $312.90M | +12.2% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $278.90M | +9.0% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $255.80M | +25.7% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $203.50M | +0.6% | 2016-03-01, From 2014-01-01 |
| 2013-12-31 | $202.20M | +16.3% | 2016-03-01, From 2013-01-01 |
| 2012-12-31 | $173.80M | +19.3% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $145.70M | +15.5% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $126.10M | +9.9% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $114.70M | -26.8% | 2012-02-24, From 2009-01-01 |
| 2008-12-31 | $156.70M | +9.9% | 2011-03-07, From 2008-01-01 |
| 2007-12-31 | $142.60M | n/a | 2010-02-24, From 2007-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $434.50M | -11.3% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $527.00M | +24.0% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $25.20M | -1.2% |
| Natera, Inc. (NTRA) | 2025-12-31 | $106.19M | +59.9% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
Compare LH, DGX, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗